Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
307 10 |
Ultima descărcare din IBN: 2023-06-04 19:28 |
Căutarea după subiecte similare conform CZU |
616.65-007.61-089 (3) |
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (392) |
SM ISO690:2012 PLEŞACOV, Alexei, VLADANOV, Ivan, GHICAVÎI, Vitalie. Contemporary surgical options in large benign prostatic hyperplasia treatment. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 4(30), pp. 32-37. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2022.4.06 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 4(30) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
DOI:https://doi.org/10.52645/MJHS.2022.4.06 | ||||||
CZU: 616.65-007.61-089 | ||||||
Pag. 32-37 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introduction. Specialists are currently interested in the method of choice for surgical treatment in patients with enlarged benign prostate hyperplasia (> 80 cm3). The introduction of laser and bipolar technologies for benign prostate hyperplasia surgery has allowed effective treatment regardless of the size of the prostate gland. Material and methods. During 2020-2021, 65 patients underwent surgical treatment for large benign prostate hyperplasia. Depending on the type of surgical treatment performed, 3 study groups were identified: 22 patients underwent transurethral Thulium: YAG laser prostate vapoenucleation; 21 patients underwent transurethral bipolar prostate enucleation; and 21 patients underwent a simple prostatectomy. All patients were examined before and after surgery (at 3 and 6 months) using the International Prostate Symptom Score, Quality of Life Score, prostate-specific antigen assessment, transrectal prostate ultrasound examination, and uroflowmetry to assess residual urine volume. Postoperative complications were recorded in accordance with the 2004 Clavien-Dindo classification. Results. There was a significant difference in the mean operative time ranging from 72±19 min (ThuVEP group) vs. 56±10 min (SP group) and 70±15 min (TUEB group), as well as a decrease in hemoglobin levels, viz. 1.2±0.4 g/dl vs. 2.6±1.1 g/dl vs. 1.6±0.5 g/dl (ThuVEP vs. SP vs. TUEB). The catheterization lasted for 2±1 days (ThuVEP) vs. 10±1 days (SP) vs. 3±1 days (TUEB). A significant improvement in Qmax was registered in the ThuVEP group (122.9%) and in the TUEB group (111.7%). However, patients after a simple prostatectomy showed an increase in Qmax of only 94%. The PVR values were reported to be the same. ThuVEP is an effective surgical technique for large BPH patients. The reduced trauma and lower complication rate of ThuVEP, as well as its effectiveness, have confirmed the need for widespread implementation of minimally invasive laser interventions. |
||||||
Cuvinte-cheie laser, bipolar enucleation, prostate |
||||||
|